Josh Color

Dr. Josh (Yoshiya) Yamada, M.D.

Dr. Yamada is an Associate Attending Radiation Oncologist and member of the brachytherapy service in the Department of Radiation Oncology at Memorial Sloan Kettering Cancer Center. He is a graduate of the Faculty of Medicine at the University of Alberta and completed residency training in Radiation Oncology at the Princess Margaret Hospital at the University of Toronto. He completed a fellowship in brachytherapy at Memorial Sloan Kettering Cancer Center and has been a faculty member in the Department of Radiation Oncology at Memorial Sloan Kettering Cancer Center for over 14 years. He has an academic interest in prostate cancer, brachytherapy, and spine radiosurgery, and has published widely on these topics. He has been invited to lecture on these topics both nationally and internationally. He and his wife Susy are the proud parents of five children. He as a special place in his heart for Australia!

Mack Color

Professor Mack Roach, M.D.

Dr. Mack Roach III, a radiation oncologist, is an internationally renowned expert in the treatment and management of prostate cancer. His research addresses new therapies such as 3-D conformal and intensity modulated radiotherapy (IMRT) as well as brachytherapy for prostate cancer. Roach chaired one of the most important clinical trials comparing different strategies for locally advanced prostate cancer. He gained international recognition as an authority on treatment planning for prostate cancer and served as senior author for the guidelines for treatment planning published by the American College of Radiology. Roach earned a medical degree at Stanford University School of Medicine. He is a member of several professional societies including the American Society of Clinical Oncology, American Society for Therapeutic Radiology and Oncology, Radiation Therapy Oncology Group, National Cancer Institute's IMRT Working Group and American Joint Commission for Cancer Staging. He is chair of Radiation Oncology and a professor of radiation oncology, medical oncology and urology at UCSF.

Matthew Color

Dr. Matthew Biagioli, M.D.

Dr. Biagioli completed his residency in radiation oncology at the University of Miami Sylvester Comprehensive Cancer Center followed by a fellowship in brachytherapy at Beth Israel Medical Center. He currently works as Clinical Director and Chief of Brachytherapy at the H. Lee Moffitt Cancer Center and Research Institute in Tampa Florida. Dr Biagioli’s clinical practice primarily involves the treatment of pelvic malignancies. His research interests include prostate HDR brachytherapy, bio-absorbable hydrogels, and texture analysis for image segmentation.

Hiroshi Color

Professor Hiroshi Tsuji, M.D.

Hiroshi Tsuji is Director of the research Program for Carbon Ion therapy and Diagnostic Imaging at National Institute of Radiological Sciences (NIRS), where he has been since 1997. He also currently serves as Head of Clinical Oncology section in the hospital of the same institute. He received a M.D. from Hokkaido University in 1982, and a Ph.D. from Tsukuba University in 1996 for his study on proton radiotherapy of hepatocellular carcinoma. He has had 30 years of experience in clinical research on radiation oncology, including 8 years in Proton therapy and 17 years in carbon ion radiotherapy. The NIRS has more than 8,000 patients experience of C-ion RT, including more than 2,000 prostate cancers. He has actually been in charge of the treatment for these patients and advancing hypofractionation based on the outcomes obtained. His current research centers on standardization and clarification of charged particle therapy, for which he works on clinical trials of hypofractionated C-ion RT for common cancers as well as establishing new treatments for radio-resistant tumors. Particularly, effective usage of newly developed scanning irradiation is a current main concern.

Carl Color

Professor Carl Rossi, M.D.

Carl Rossi, MD, is a radiation oncologist specializing in proton beam therapy, specifically for prostate cancer and lymphomas. He is also the current medical director for the Scripps Proton Therapy Center, which will provide treatment to target tumors with high control and precision. In addition to treating a variety of cancers with radiation, it is also used to treat some non-cancerous conditions. Dr. Rossi has a research focus on the quality of life and cure rate in prostate cancer and lymphoma treated with proton beam radiation. He believes in treating his patients as equal partners throughout the treatment process. This involves open, honest communication, including what the treatment will entail and the pros and cons of the treatment course. With this information patients can make informed decisions. He also wants his patients to feel supported in whatever path they choose to take with regard to their treatment plan. When he is not caring for patients or conducting research at Scripps Proton Therapy Center, he enjoys running, cycling, travelling and flying.

Morton Color

Professor Morten Høyer, M.D

Dr Morten Høyer is Professor and Consultant at the Department of Oncology at Aarhus University Hospital. He has special interest in stereotactic radiotherapy of tumours of the brain, lung and liver and in radiotherapy of prostate cancer. His PhD at Aarhus University in 1994 was based on a thesis on studies of cancer cell kinetics and he had his postgraduate specialty training at Aarhus University Hospital and Copenhagen University Hospital, Herlev. He is involved in the establishment of the Danish Center for Particle Therapy and member of the board of the Danish Prostate Cancer Group.

Patrick Color

Professor Patrick Kupelian, M.D.

Dr. Kupelian is a Professor of Radiation Oncology and Vice-Chair of Clinical Operations and Clinical Research at UCLA. He completed his residency training in radiation oncology at the University of Texas M.D. Anderson Cancer Center in Houston, and completed a fellowship in genitourinary malignancies at the Cleveland Clinic Foundation. Following his fellowship, he was the section head of genitourinary malignancies in the Department of Radiation Oncology at the Cleveland Clinic for 8 years. He also served as the Clinical Research Director of the Department of Radiation Oncology at the Cleveland Clinic Foundation. Dr. Kupelian was the Chairman of the Radiation Oncology Department and Scientific Director of Research at M.D. Anderson Cancer Center in Orlando, FL, and a Professor at the University of Central Florida Although he specializes in genitourinary malignancies, he an internationally known expert in the development and evaluation of cutting edge technologies in Radiation Oncology for a variety of anatomic sites. He has pioneered high-dose hypofractionated radiation therapy for prostate cancers. He has also played a significant role in the introduction and implementation of multiple image guidance techniques in radiotherapy. He has authored more than 180 research papers, multiple review papers and book chapters. He is Board certified in Radiation Oncology. He is a member of the American Society of Therapeutic Radiation and Oncology (ASTRO), the European Society of Therapeutic Radiology and Oncology, American Society of Clinical Oncology, the American Urological Association and the American Brachytherapy society. He has served on many committees within ASTRO. He is a reviewer for several medical journals including International Journal of Radiation Oncology Biology Physics, the Journal of Urology, Radiotherapy and Oncology, Cancer, the Journal of Clinical Oncology, the British Journal of Urology, and Physics in Medicine and Biology. He is active in national and international lecture series. He has conducted multiple educational courses at ASTRO and RSNA among others.

Mitchell_Kamrava Colour

Dr. Mitchell Kamrava

Dr. Mitchell Kamrava is an assistant clinical professor and member of the brachytherapy division in the Department of Radiation Oncology at the University of California, Los Angeles. After receiving his medical degree from the University of California, San Diego (UCSD) Medical School, he completed residency training at the National Cancer Institute, and further advanced his skills by doing a brachytherapy fellowship at the University of California, Los Angeles. He serves as a Co-editor for the Journal of Contemporary Brachytherapy as well as an editor for the journal Brachytherapy. He’s spoken on focal therapy for prostate cancer both nationally and internationally and has opened an investigator-initiated trial of prostate focal therapy. He was awarded a Career Development Award to investigate targeted tissue acquisition during prostate radiotherapy, and exploration of the effects of radiation treatment on neuroendocrine markers. Dr. Kamrava was also selected Super Doctor Southern California Rising Star in 2013 and 2014.